The Natural Sciences and Engineering Research Council of Canada (NSERC) and the US National Science Foundation (NSF) are pleased to announce a Flash Call for letters of intent (LOIs) with an expedited evaluation and decision process for LOIs. Under this Flash Call, LOIs directed to research projects in quantum technologies that aim to advance one or more of the National Quantum Strategy missions will be reviewed by NSERC, and a decision will be provided within approximately 2 weeks of receiving the complete LOI.

For more information, please contact Jill Sherman at intl.research@lakeheadu.ca.

Faculty Innovation Award

Brain Canada along with Heart & Stroke, the Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health (CIHR-ICRH), and CIHR Institute of Genetics (IG) are excited to launch the Congenital Heart Disease (CHD) Team Grants.  

Objectives

Research Tools and Instruments (RTI) grants foster and enhance the discovery, innovation and training capability of university researchers in the natural sciences and engineering by supporting the purchase of research equipment.

Description

The RTI grants program provides the primary avenue for university researchers in the natural sciences and engineering to obtain up to $150,000 in support for research tools and instruments with a net cost between $7,001 and $250,000. Net cost is defined as the purchase cost of the equipment after any discount from the vendor and before taxes, customs and importation fees, transportation and shipping charges, and assembly and installation costs. The vendor discount  cannot be offered in exchange for services from users benefiting the vendor company. The research community is also encouraged to explore other avenues for funding research tools and instruments, including NSERC’s other programs that allow the purchase of equipment as eligible expenses.

SICI seeks Project Proposals from faculty members of our Canadian Universities to develop an ASII Project Proposal in collaboration with a faculty member from an Indian university. The Proposal will detail plans, approaches and procedures to lead a Semester in India Project, taking 15 Canadian undergrad students to the partnering host Indian University for 13 weeks. This new pilot project will initiate the process of Course Credits and or Credit transfer mechanisms between SICI's Canadian and Indian member institutions, which would immensely benefit our Canadian students. Deadline to submit: August 15, 2023.  Click here for full details. l Contact Jill Sherman for more information at intl.research@lakeheadu.ca.

Accepting Nominations until September 15, 2023.

The Health Research Foundation (HRF) is pleased to announce that nominations are now open for the 2023 Diversity and Equity in Research Award. This new award recognizes a remarkable individual whose research demonstrates the highest quality of excellence and advances equitable participation in health research and access to health care in Canada, improving the well-being of all Canadians, particularly those facing inequities.

Award applicants should demonstrate positive contributions towards a more inclusive research community and society, in addition to improving access to health care by removing economic, social, and other barriers.

To nominate an outstanding individual, complete the nomination form at hrf-frs.com/awards by September 15, 2023.

For more information on the HRF, visit: hrf-frs.com.

If you are interested in being nominated for this award, please contact Dr. Batia Stolar, Associate Vice-President, Research and Graduate Studies, at bstolar@lakeheadu.ca.

The Public Health Agency of Canada is pleased to share with you the following Open Call for Letters of Intent under the Transmission Dynamics of Respiratory Infectious Diseases – Research Funding Opportunity:

https://www.canada.ca/en/public-health/services/funding-opportunities/grant-contribution-funding-opportunities/transmission-dynamics-respiratory-infectious-diseases-research-funding-opportunity.html

The purpose of this call for letters of intent (LOI) is to fund Canadian research that investigates the transmission dynamics of respiratory infectious diseases, such as COVID-19, influenza, and respiratory syncytial virus (RSV). This opportunity is a two-stage process that involves assessing submitted LOIs and inviting research teams of approved projects to submit a full funding request. Multiple research projects will be funded, subject to budgetary and project considerations.

Should you wish to apply, please email: cgc.solicitations-csc@phac-aspc.gc.ca with the subject line “LOI Transmission Dynamics of Respiratory Infectious Diseases” to obtain the letter of intent template.

The deadline for submissions is 12:00 pm (ET) on August 11, 2023.

The specific objectives of this funding opportunity are to:

• Address the biological, social, environmental and/or behavioural effects on lung health through rigorous research approaches informed by intersectional analyses;
• Coordinate the collection and sharing of data to understand, prevent, detect and manage lung health to improve reproducibility and rigour of research results;
• Disseminate, inform and implement high-quality evidence into practice and policy for improved and more equitable health outcomes;
• Strengthen and promote lung health research capacity through interdisciplinary and experiential-based approaches to foster the next generation of lung health researchers;
• Meaningfully integrate equity, diversity and inclusion analyses and considerations within research studies and teams;
• Broadly strengthen the respiratory health and wellness of people living in Canada with meaningful consideration of historically excluded groups and Indigenous Peoples (First Nations, Inuit, and Métis).

This funding opportunity will support projects relevant to at least one of the following research areas:

• Clinical trials for new or repurposed drugs (including vaccines and biologic drugs) and medical devices (such as diagnostic tests) to prevent or respond to health emergencies.
• Early phase (pilot, Phase 1 and Phase 2) clinical trials of safety and efficacy to support the development and commercialization of new health products with high potential to solve current and future health challenges (such as pandemics, antimicrobial resistance, and other health emergencies)
  • New health products of particular interest for this opportunity include those in emerging technology areas (e.g., precision medicines, including cell and gene therapies, RNA, and viral vectors, and monoclonal antibodies).

The specific objectives of this funding opportunity are to:

• Support the growth of emerging research foci and priorities that have the potential to advance the health and well-being of youth in Canada;
• Support the development of collaboration, both within the research community, as well as with knowledge users, policy makers and other key partners, including youth, that will enhance interdisciplinary and cross-sectoral approaches to research and knowledge mobilization; and
• Build capacity, both in terms of the researcher career pathway, and the engagement of youth throughout the research process to enhance youth health research.